Detalhe da pesquisa
1.
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Haematologica
; 104(1): 147-154, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115656
2.
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
Hematol Oncol
; 35(4): 497-503, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27530779
3.
Enhanced THz extinction in arrays of resonant semiconductor particles.
Opt Express
; 23(19): 24440-55, 2015 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406649
4.
Cytarabine dose for acute myeloid leukemia.
N Engl J Med
; 364(11): 1027-36, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21410371
5.
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.
Am J Hematol
; 89(4): 355-62, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24273190
6.
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.
Blood
; 118(5): 1239-47, 2011 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670471
7.
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.
Haematologica
; 98(6): 980-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23445873
8.
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.
Haematologica
; 98(1): 87-94, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875621
9.
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Blood
; 113(6): 1375-82, 2009 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18988865
10.
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study.
Exp Hematol
; 89: 55-60.e6, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781097
11.
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.
Haematologica
; 92(7): 928-35, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17606443
12.
Selective detection of bacterial layers with terahertz plasmonic antennas.
Biomed Opt Express
; 3(11): 2937-49, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23162730
13.
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.
J Clin Oncol
; 30(24): 2946-55, 2012 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22802322
14.
Universal scaling of the figure of merit of plasmonic sensors.
ACS Nano
; 5(6): 5151-7, 2011 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21574624
15.
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study.
J Clin Oncol
; 28(19): 3160-6, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516439
16.
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program.
Clin Lymphoma Myeloma Leuk
; 10(2): 138-43, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20371448
17.
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.
Blood
; 101(6): 2144-51, 2003 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12456509